CAPS Rating

Wankelman (99.50)

Results 1 - 20 of 136 : 1 2 3 4 5 6 7 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
08/07/2008 IQI.US 1 out of 5 Underperform 3Y $8.89 $13.28 (+0.45%) +49.39% +38.61% -10.78
10/04/2008 KGRZF.US No stars Outperform 5Y $3.95 $0.09 (0%) -97.59% +26.52% -124.12
01/04/2008 PM.US 5 out of 5 Outperform 5Y $40.37 $95.00 (-0.71%) +135.33% +27.63% +107.70
25/12/2007 OGZPY.US 3 out of 5 Outperform 5Y $28.95 $8.05 (+0.63%) -72.19% +17.45% -89.64
07/11/2007 DDT.US No stars Underperform 5Y $11.04 $26.02 (-0.15%) +135.59% +16.32% -119.27
16/10/2007 NVR.US 2 out of 5 Underperform 3Y $431.16 $1,001.45 (-0.45%) +132.27% +13.60% -118.67
14/09/2007 URZ.US 2 out of 5 Underperform 5Y $3.45 $1.42 (+5.19%) -58.81% +18.42% +77.23
11/09/2007 HSYT.US 1 out of 5 Underperform 5Y $4.01 $0.52 (0%) -87.03% +19.26% +106.30
14/08/2007 CYXI.US No stars Outperform 5Y $3.00 $0.00 (0%) -99.89% +22.03% -121.93
26/07/2007 SCOR.US 2 out of 5 Outperform 3Y $23.14 $20.29 (+0.20%) -12.32% +17.08% -29.41
26/07/2007 MEDQ.US No stars Underperform 3Y $6.20 $8.50 (0%) +37.18% +17.08% -20.10
26/07/2007 MPAA.US 3 out of 5 Underperform 1Y $12.45 $6.29 (+0.48%) -49.48% +17.08% +66.56
25/07/2007 NNRI.US No stars Underperform 3Y $3.08 $0.00 (+33.33%) -99.99% +15.79% +115.78
25/07/2007 KDKN.US No stars Underperform 5Y $2.67 $0.01 (-0.89%) -99.58% +15.59% +115.18
25/07/2007 TOT.US 5 out of 5 Outperform 5Y $61.13 $50.65 (+0.70%) -17.15% +15.59% -32.74
23/07/2007 NENE.US 1 out of 5 Underperform 5Y $7.95 $2.05 (-5.09%) -74.21% +13.81% +88.03
19/07/2007 SCEY.US No stars Underperform 5Y $3.38 $0.00 (0%) -99.91% +13.31% +113.22
17/07/2007 ITCD.US 1 out of 5 Underperform 5Y $8.90 $2.99 (0%) -66.40% +13.12% +79.52
01/06/2007 BIF.US 5 out of 5 Underperform 5Y $8.06 $7.68 (+0.13%) -4.72% +14.69% +19.41
01/06/2007 ABAT.US 2 out of 5 Underperform 5Y $2.90 $0.28 (-6.35%) -90.34% +14.69% +105.03
Results 1 - 20 of 136 : : 1 2 3 4 5 6 7 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.